Weekly Market Report · Issue 11
The AI Trade Cracked. The Rest of the Market Didn’t.
The Nasdaq lost 4.5% in the week of October 12–16, but the Dow gained 0.7% and roughly 70% of S&P 500 stocks advanced. A credit-driven repricing of AI infrastructure collided with hot inflation and elevated oil prices. This week: Vince’s seven chart setups, Allstate’s underwriting-cycle research, and the $745 billion AI-financing debate.
The issue at a glance
The Two-Minute Brief
Prices through October 16, 2026 · 4:00 PM ET
Index-level weakness concealed substantial rotation: the S&P 500 fell 1.9% while the equal-weight market and many defensive groups were firmer. Tech/AI funding risk has become an immediate cross-asset issue.
Weekly ETF price returns: XLK −7.70%; XLP +5.02%; XLE +4.86%; XLV +3.45%. Separate from Vince’s VMF order.
- The Nasdaq Composite fell 4.5%, S&P 500 fell 1.9%, Russell 2000 fell about 3.0%, and Dow gained 0.7% for the week.
- Technology declined about 6.4% while roughly 70% of S&P 500 constituents gained. Narrow index concentration can hide improving participation elsewhere.
- AI’s debt-intensive buildout is being stress-tested in both credit and equities; protect against correlated positions while waiting for earnings and credit-market confirmation.
CoreWeave debt stress, semiconductor selling and concern about AI capex returns make credit spreads, refinancing costs and management guidance key signposts.
MAR, MSI, AIZ, EWC, EWU, KKR and ALL. Vince’s chart interpretations, independently ranked VMF board and an insurance-cycle valuation study.
Interpretation, not information
Vince’s View
The headline index breakdown was not a synchronized exit from equities. It was a sharp repricing of capital-intensive technology while an unusually large proportion of stocks rose. That is a fundamentally different tape from an indiscriminate liquidation.
The immediate pressure point was AI financing. CoreWeave’s debt repricing and steep share decline sharpened investors’ focus on the difference between contracted demand, financeable construction and cash actually available to shareholders. A future revenue backlog is not the same as free cash flow. Credit spreads and the terms of fresh debt issuance may now matter as much as GPU shipment forecasts.
The other half of the story is rotation. Approximately seven in ten S&P 500 constituents rose last week while the cap-weighted benchmark declined about 2%. Defensive groups and previously overlooked businesses found demand. Treasuries rallied, pushing the 10-year yield toward 5.08%–5.10%, even as September inflation and oil prices remained troublesome. This makes the rates signal more nuanced: the bond bid may reflect risk aversion rather than confidence in rapid disinflation.
Vince’s VMF remains an independent structural ranking. Energy is #1, Health Care #2 and Consumer Staples #3, while Industrials rank #12. We should not infer that the VMF hierarchy is simply the week’s total-return leaderboard.
Trend, participation and cross-asset evidence
Market Regime Dashboard
October 12–16: S&P 500 −1.9%, Nasdaq −4.5%, Dow +0.7%. Friday S&P close: 7,659.44; Nasdaq: 26,140.03; Dow: 52,002.41. A tech-heavy downturn, not a uniform Dow-led decline.
About 70% of S&P 500 stocks rose despite a roughly 2% fall in the cap-weighted index. The equal-weighted benchmark advanced for a second week, supporting a rotation interpretation.
10-year Treasuries finished near 5.08%–5.10%; yields fell substantially on the week despite above-target inflation. Evaluate risk aversion and growth expectations before treating falling yields as automatically bullish.
Brent rose toward $110/bbl on Middle East supply concerns. September CPI was 3.7% headline and 2.6% core, adding tension to the Fed’s policy choices.
CoreWeave credit-market stress and weakness in AI-linked debt raised questions about the durability and cost of AI infrastructure funding. Watch high-yield versus investment-grade spreads and new-issue financing terms.
Broadening participation provides a positive counterweight; the rapid repricing of concentrated tech exposures, elevated crude and interest-rate uncertainty argue against an unqualified risk-on label.
Ranked strictly by Vora’s VMF
Sector Analysis
VMF is Vince’s independent October 18 ranking, not weekly price-performance order. Weekly price changes are verified unadjusted ETF closes from October 9 to October 16, 2026, sourced from ChartExchange; distributions excluded. XRT is an equal-weight retail proxy, not an S&P sector SPDR.
| VMF | Group / proxy | Interpretation for the coming week | Week Oct 12–16 |
|---|---|---|---|
| 1 | XLE — Energy | Oil and supply risks bolster relative attention; watch whether gains persist despite crude volatility. | +4.86% |
| 2 | XLV — Health Care | Relative defensive appeal; earnings and regulatory catalysts still matter. | +3.45% |
| 3 | XLP — Consumer Staples | Potential refuge from concentration and consumer affordability concerns. | +5.02% |
| 4 | XLF — Financials | Bank earnings point to resilient lending, but reserves and funding costs remain critical. | +1.44% |
| 5 | XRT — Retail · equal-weight proxy | Divergence within consumer spending; scrutinize mix and margin commentary. | +3.48% |
| 6 | XLK — Technology | AI infrastructure debt and capex profitability drive acute price dispersion. | -7.70% |
| 7 | XLB — Materials | Cyclical exposure balanced by rotation and input-price pressure. | +3.01% |
| 8 | XLC — Communication Services | Platform concentrations expose this group to tech valuation reassessment. | -0.05% |
| 9 | XLU — Utilities | Capital-intensive balance sheets and yields compete with defensive demand. | +1.93% |
| 10 | XLY — Consumer Discretionary | Consumer inflation exposure plus select mega-cap concentration. | -0.35% |
| 11 | XLRE — Real Estate | Refinancing stress versus falling Treasury yields; highly company-specific. | +1.32% |
| 12 | XLI — Industrials | Vince’s weakest VMF rank; select infrastructure demand against financing pressure. | -0.88% |
Seven setups · seven charts · October 18, 2026
Technical Setups
Seven weekly technical setups from Vince Vora, with chart analysis and an individual video briefing for each. Click any chart to enlarge.
Constructive multi-quarter consolidation. Holding its rising 40-week average; a decisive break above upper resistance implies uncharted upside. Weekly close below ~$425 invalidates.
Technical targets are scenarios rather than guaranteed outcomes; watch the stated invalidation levels.
Stage 2 uptrend; rebound at 40-week average. Fibonacci targets $329.88 and $363.11. Weekly close below average / swing support near $260 invalidates.
Technical targets are scenarios rather than guaranteed outcomes; watch the stated invalidation levels.
Stage 2 uptrend; support test. Targets $65.54 and $69.07. Weekly close below average and ~$57.50 local support invalidates.
Technical targets are scenarios rather than guaranteed outcomes; watch the stated invalidation levels.
Stage 2 uptrend; orderly pullback. Targets $52.81 and $58.70. Weekly close below average and ~$45 local low invalidates.
Technical targets are scenarios rather than guaranteed outcomes; watch the stated invalidation levels.
Weak below declining 40-week average. Short-side watch: a weekly close below $85–$90 exposes ~$60; weekly recovery above declining average / ~$100 invalidates.
Technical targets are scenarios rather than guaranteed outcomes; watch the stated invalidation levels.
Stage 2 uptrend; defended support. All-time-high structure remains constructive. Weekly close below 40-week average and ~$220 swing support invalidates.
Technical targets are scenarios rather than guaranteed outcomes; watch the stated invalidation levels.
Featured fundamental research
Featured Research · Allstate (ALL)
Allstate
The third-largest US personal lines insurer is coming off the most profitable twelve months in its history: a 44% adjusted return on equity, an underlying combined ratio near 79 and $11.9B of adjusted net income. At $247.88 the shares trade at 5.5x trailing adjusted earnings, a number that looks cheap and is not the right lens. Auto insurance prices are now falling nationally, reserve releases have been doing a fifth of the work, and consensus already has 2027 earnings 21% below 2026. The real question is what return on equity Allstate earns through the cycle, and how much of that the 2.0x book multiple already assumes.
A record year built on three tailwinds that are fading at the same time
Allstate sells car and home insurance. It collects premiums up front, pays claims later, and earns money two ways: an underwriting margin (premiums minus claims and expenses, measured by the combined ratio, where below 100 is profit) and investment income on the float in between. After the 2022 to 2023 loss years, when used-car and repair inflation pushed the combined ratio above 100 and adjusted earnings to a loss, Allstate and the industry raised auto rates hard. Those increases have now largely earned in, and the result looks like a peak: trailing adjusted EPS of $45.12, a trailing adjusted ROE of 44.2% and a property-liability combined ratio of about 80 over the last four quarters.
Three things lifted those numbers, and each is turning. Pricing: the BLS motor vehicle insurance index was 5.0% lower in September than a year earlier, the fifth straight year-on-year decline; Allstate's own auto rate changes were flat in Q2 and it cut premiums for 7.8 million customers in 2025. Reserve releases: favorable prior-year development added roughly $8.70 a share to trailing adjusted EPS (our estimate), about a fifth of the total, and not something that can be planned on. Catastrophes: trailing cat losses ran at about 6.3 points of premium, below Allstate's 2023 to 2025 average of 9.8 points, and Q3 2026 alone carried $1.65B. Consensus already reflects this: FY2026 EPS of $35.62 and FY2027 of $28.11, a 21% decline. So the 5.5x trailing P/E is the classic cyclical trap. The better lens is price to book (2.0x) against a sustainable return on equity. Depending on the cost-of-equity and growth assumptions, today's price implies roughly 14% to 20%, centred near 17%; Allstate's ten-year average combined ratio, applied to today's investment income, would produce about 15% to 16%. The macro backdrop pulls both ways: the Fed raised rates to 3.75%–4.00% on 16 September and the 10-year Treasury yield reached 5.26% in early October, which lifts reinvestment yields on an $88B portfolio but marks down the bonds already held, and repair costs are still rising (+5.8% a year in the September CPI) while auto insurance prices fall.
A round trip through September, and a quiet October rebound
Allstate closed at $247.88 on 16 October 2026, 10.6% below its 52-week high of $277.22 set in July and about 32% above its 52-week low of roughly $188 from late 2025. On a dividend-adjusted basis the shares are up about 18% since September 2025 month-end, slightly ahead of the S&P 500 (SPY) at about 16%. The path was anything but smooth: the stock rose about 29% between the May and July month-ends after a 47% first-quarter earnings beat and a run of lighter storm months, then fell 14% in September (including a 5.2% one-day drop on 22 September) as heavy July and August catastrophe losses ($682M and $748M) met growing talk of softer auto pricing. October has recovered about 12% as September catastrophe losses came in light ($220M).
Exhibit 1 shows a stock that has tracked catastrophe headlines more than fundamentals. The two big up-moves (November 2025 and May to July 2026) followed reports in which adjusted EPS beat consensus by 36% and 47%, and the September slide came with no change in reported numbers, only the monthly cat releases and the September FOMC hike. Over the full twelve months, trailing adjusted EPS rose from $21.05 (four quarters to June 2025) to $45.12 while the shares returned about 18%, so the trailing multiple compressed from about 10x to 5.5x. The market is treating the earnings jump as cyclical, which in our view is the right instinct; the debate is about how far it reverses.
Price = 16 Oct 2026 close ($247.88). TTM = four quarters to 30 Jun 2026 (revenue $70.1B; net income to common $13.19B; adjusted net income $11.89B; P-L premiums earned $59.0B; underwriting income $11.56B). Share basis: 253.5M common shares outstanding at 30 Jun 2026 (the latest reported count; repurchases have continued since). Market cap = shares × price. "Enterprise value" adds $7.49B debt and $2.05B preferred liquidation value; for an insurer EV and EBITDA multiples are not meaningful because debt funds the holding company, not operations, and the investment portfolio backs claim reserves. Book value per share is the company-reported figure; ex-AOCI adds back $193M of accumulated other comprehensive losses; ex-goodwill removes $3.12B of goodwill only. Underlying combined ratio is premium-weighted across the four quarters. Beta computed from 60 monthly returns (Oct 2021 to Sep 2026, correlation with SPY 0.09); it understates the stock's real risk, which is catastrophe and pricing-cycle risk the market index does not capture. Cost of equity ~9.5–10.5% is an assumption (10-yr Treasury 5.26% plus a 4–5 point premium), not CAPM. Consensus EPS and analyst counts: Alpha Vantage estimates (21–23 analysts), shown in amber. Rating and targets: Barchart (24 analysts: 10 Strong Buy, 10 Hold, 4 Strong Sell) and Benzinga, September 2026; ranges differ by source. Institutions: 13F filings, Q1 2026 (other sources show 59% to 85%). Short interest: Equibles and Benzinga, Aug–Sep 2026. Holding company capital: management on the Q2 2026 call. Statutory surplus, RBC and dividend capacity: 2025 Form 10-K (company estimates at 31 Dec 2025; AIC = Allstate Insurance Company, the main operating insurer; ACL = authorized control level). Operating cash flow is shown without a yield: for an insurer it includes premiums collected before claims are paid.
The numbers everyone quotes, and where they mislead
1. A 5x P/E at a cyclical peak. GAAP TTM P/E is 4.9x and adjusted 5.5x. Both rest on a year with heavy reserve releases and below-normal catastrophes. On consensus 2027 earnings the multiple is 8.8x, and Allstate's own 2022 and 2023 show what the trough looks like: adjusted losses. Low multiples on peak earnings in a cyclical business are a warning, not a signal. 2. "Revenue +11.8%" is mostly not premium. Q2 total revenue included $1.06B of net investment gains, which swing with markets. Property-liability premiums earned grew 4.0%, and premiums written, the leading indicator, grew 2.6%; auto written premiums grew only 0.4%. 3. "Adjusted" removes investment marks but keeps reserve releases. Adjusted EPS of $8.99 in Q2 excludes $4.07 of investment gains and $0.57 of pension gains (good), but includes about $2.09 a share of favorable prior-year reserve development (our estimate), which is real profit but not repeatable at will. 4. Even the "underlying" auto ratio is flattered. The underlying auto combined ratio of 87.6 in Q2 excludes prior-year reserve changes, but the company disclosed it still benefited from 2.4 points of favorable development on claims reported in Q1 2026; adjusted for that, it was about 90.0. 5. Operating cash flow is float, not owner earnings. Operating cash flow less capex was $12.2B over four quarters, but an insurer's operating cash flow includes premiums collected before claims are paid; it is not distributable cash, and we do not quote a yield on it. The cash measures that matter are statutory earnings, what the insurance subsidiaries can pay up to the parent, and what the parent returns (Section 3). 6. Policy growth has a catch-up in it. Total policies in force rose 3.8% to 215.9M, but the June count includes 2.9M policies relating to September 2025 to March 2026 that had not been reported before, mostly in Protection Services. Property-liability policies grew 2.6%. 7. Data-feed artifacts. Generic feeds show a "gross margin" and a current ratio for Allstate; neither means anything for an insurer, and one feed maps Q3 2025 net income at $2.04B in its cash-flow table versus the reported $3.75B.
Scale, brand and a homeowners franchise, in a business where price is the product
What it does. Allstate insures cars, homes and other personal property across the US, mainly through the Allstate Protection segment (2025 premiums written: auto $38.6B, homeowners $16.6B, plus specialty and commercial lines), sold through exclusive Allstate agents, independent agents (the Custom360 product, now in 41 states) and directly. A smaller Protection Services segment (about $0.9B of revenue a quarter) sells device and appliance protection plans through retailers, roadside assistance, dealer products, identity protection and Arity, a telematics and lead-generation business. In 2025 Allstate sold its Employer Voluntary Benefits and Group Health businesses, booking about $1.6B of disposition gains, so it is now almost purely a property-liability company. Tom Wilson leads the company; Christian Lown became CFO on 3 August 2026.
Revenue drivers, decomposed (Q2 2026 vs. Q2 2025). Auto (about two-thirds of property-liability premium): written premium +0.4% on policies in force +2.8%, so average premium fell. Annualized premium per auto policy was $1,486, down slightly, and management said rate changes had a net impact of zero in Q2 after 2.6% in 2025. New auto business rose 8.8%, credited to "affordability initiatives", distribution and marketing. This is volume bought with price. Homeowners: written premium +8.1%, from a 5.8% rise in Allstate-brand average premium (rate increases and higher replacement costs) and 2.9% more policies, with new business +16.4%. This is price plus volume. Investments: net investment income +33.8% to $1.01B, with market-based income +14.2% on larger balances and higher yields.
Exhibit 2 is the whole story in one picture. Premiums earned rose 9% over two years while adjusted net income went from about $1B to $2.3B–$3.8B a quarter. That is operating leverage from price catching up with claim costs, not from a bigger business, and it is the part of the cycle that does not last. Earnings have already rolled over from the Q4 2025 peak ($3.79B, helped by a 1.4-point catastrophe quarter) to $2.33B in Q2 2026 as storms returned.
Competitive position. Allstate is the third-largest US personal lines writer behind State Farm and Progressive by premium. It is gaining share in many states: management cited share gains in auto and homeowners on the Q1 call, and new business is growing at high single to double digits. But rivals are doing the same with deeper margins or bigger ad budgets: Progressive grew policies 6.3% in Q3 at an 88.7 combined ratio, State Farm cut auto rates an average 10% across 40 states, and GEICO's combined ratio rose to 91.2 in Q2 from 83.5 as it cut prices. When every large writer is cutting price at once, customers shop more and retention becomes the battleground.
Moat & pricing power: what the numbers show. Narrow, and the evidence sits in underwriting results rather than in size. Over the past ten years Allstate's auto combined ratio averaged 95.2 versus 100.3 for the industry, and homeowners 92.0 versus 102.2 (company figures, Q2 2026 investor presentation): a durable 5 to 10 point margin advantage, largest in homeowners, where catastrophe modelling, pricing segmentation and reinsurance buying matter most. The cost side is less distinctive: the property-liability expense ratio was 21.4 in 2025, of which advertising was 3.6 points (up from 1.3 in 2023), against GEICO's 14.6 in Q2 2026 (definitions differ by company). Growth is being bought: auto new business rose 8.8% in Q2 while policies in force grew 2.8% and written premium 0.4%, with annualized premium per auto policy at $1,486. Allstate does not publish a numeric retention ratio; management described retention on the Q2 call as having "stabilized". Bundling penetration is not disclosed. On the evidence available, the advantage is in risk selection and homeowners underwriting rather than in a lower cost base or in pricing power. Auto is a regulated, rate-filed product that customers can compare in minutes, and pricing power has appeared only when the whole industry was short of margin, as in 2023 to 2024.
Peers on the same page
| Metric | Allstate | Progressive | GEICO | State Farm |
|---|---|---|---|---|
| Auto combined ratio (recorded) | 83.3 (Q2'26) | 88.7, company-wide (Q3'26) | 91.2 (Q2'26) | ~93.5 (FY25, derived) |
| Auto underlying combined ratio | 87.6; ~90.0 excl. current-year benefit | n/d | n/d | n/d |
| Prior-year reserve development | 4.6 pts favorable, P-L (Q2'26) | n/d | "relatively insignificant" (H1'26) | n/d |
| Auto policy growth | +2.8% (Q2'26) | ~+7% personal auto (30 Sep) | n/d | n/d |
| Written premium growth | Auto +0.4%; P-L +2.6% (Q2'26) | +4% (Q3'26) | +1.1% (Q2'26) | n/d |
| Expense ratio | 21.4, P-L (FY25) | n/d | 14.6 (Q2'26) | n/d |
| Pricing direction | Auto rate impact ~0 (Q2'26) | Premium per auto policy about −3% | Cutting price; CR +7.7 pts | ~$4.6B a year of auto cuts in 40 states |
| Return on equity | 49.1% GAAP · 44.2% adj. (TTM) | 32.5% (Q2'26) | n/a (Berkshire unit) | n/m (mutual) |
| Price / book | 2.01x | 3.70x | n/a | n/a |
n/d = not disclosed in the sources reviewed. Allstate: Q2 2026 release and 2025 10-K. Progressive: September 2026 monthly release (combined ratio and policies in force; personal auto = agency + direct auto) and Q2 2026 results via Zacks (book value per share $59.05, ROE); P/B = $218.49 close on 16 Oct 2026 ÷ $59.05. GEICO: Berkshire Hathaway Q2 2026 10-Q as summarized by actuary.info. State Farm: 2025 results release (26 Feb 2026); auto combined ratio derived from $52.6B incurred claims plus $14.1B expenses on $71.3B earned premium. Periods differ by company and are shown in each cell.
The table supports the margin-cushion argument, with a caveat. Allstate's recorded Q2 auto ratio was 5 to 10 points better than the three largest competitors, but 6.6 of those points were prior-year releases; excluding them it was about 90, still better than GEICO's 91.2 but close to Progressive's company-wide 88.7, while Progressive is growing auto policies at more than twice Allstate's rate. Progressive trades at 3.7x book on a 32.5% ROE; Allstate at 2.0x on a higher but more reserve-dependent ROE.
Concentration. No customer concentration, but heavy concentration by product and peril: US personal auto is about 65% of property-liability premium, and homeowners carries most of the catastrophe exposure (in Q2 2026, $1.41B of the $1.72B catastrophe total was homeowners). Severe convective storms (wind and hail) drive most losses; 2026 Q3's $1.65B came from dozens of events, about half of August's from one storm. The January 2025 California wildfires made Q1 2025 the heaviest catastrophe quarter in the period shown in Exhibit 3 (15.7 points).
Real earnings, but a fifth of them came from re-estimating old claims
How to read an insurer's quality of earnings. The combined ratio splits into three pieces: the underlying margin on this year's business, catastrophe losses (volatile, largely weather), and prior-year reserve development (changes to estimates of claims from earlier years). Underlying margin is the repeatable part. Exhibit 3 separates them.
Exhibit 3 makes three points. First, the underlying combined ratio fell from about 83 in 2024 to a low of 76.6 in Q4 2025 and has since drifted back to 79 to 80: the largest benefit from prior rate increases appears to have been realized, and the underlying margin is now stabilizing or normalizing rather than improving. Second, reserve releases went from slightly adverse in 2024 to 5.4, 6.9 and 4.6 points in the last three reported quarters. Allstate lowered prior-year auto reserves by $838M in Q1 2026 alone as 2023 to 2025 claim costs came in below estimates; auto releases total about $1.5B so far this year, and the company says about 51% of the auto injury releases related to accident years 2023 and 2024 and 30% to 2025. Over the past four quarters, non-catastrophe releases were worth about $2.9B pre-tax, roughly $8.70 of the $45.12 in trailing adjusted EPS. Third, catastrophes were unusually light in Q3 and Q4 2025 (3.8 and 1.4 points) and have returned: Q2 2026 was 11.5 points and Q3 2026 will be about 11 on disclosed losses. Through September, catastrophe losses ($4.61B) are broadly comparable with the prior-year period ($4.75B), but that does not by itself establish a normal burden: full-year catastrophe ratios were 11.6, 9.2 and 8.6 points in 2023, 2024 and 2025, and rising property values, rebuilding costs and peril mix mean a simple historical average may understate the forward load. What is clear is that the comparison with last autumn's 3.8 and 1.4 points is hard.
The releases are not a red flag in themselves. They reflect severity that came in below the cautious assumptions set during the inflation spike, and they are audited re-estimates, not accounting choices made in the quarter. But they are finite. Reserves for claims fell from $43.1B at September 2025 to $41.0B at June 2026 while premiums grew, which is consistent with releases and with paying down 2025 wildfire claims. Consensus models generally assume none. If they stop, adjusted earnings lose roughly $2 a share per quarter at the recent pace.
| Per diluted share | Q2 2026 | 6M 2026 | FY 2025 | Recurring? |
|---|---|---|---|---|
| GAAP EPS (to common) | $12.51 | $21.73 | $38.06 | |
| Net (gains) losses on investments & derivatives | (4.07) | (2.49) | +0.63 | Market-driven |
| Pension remeasurement (gains) losses | (0.57) | (0.49) | (0.13) | Market-driven |
| Amortization of purchased intangibles | +0.18 | +0.36 | +0.86 | Ongoing, non-cash |
| Gain on disposition | 0.00 | (0.03) | (6.05) | One-off (2025 sales) |
| Tax on adjustments | +0.94 | +0.57 | +1.46 | |
| Adjusted EPS | $8.99 | $19.65 | $34.83 | |
| Memo: favorable non-cat reserve development inside adjusted (after tax, est.) | ~2.09 | ~5.17 | ~5.29 | Not reliably |
| Memo: catastrophe losses inside adjusted (after tax) | (5.25) | (8.97) | (14.67) | Yes, but lumpy |
Source: Q2 2026 and Q4 2025 earnings releases (GAAP to adjusted reconciliations). Memo rows are newsletter estimates: reserve effect = disclosed points × premiums earned × (1 − 21%) ÷ diluted shares; catastrophe losses × (1 − 21%) ÷ diluted shares. Columns may not sum exactly due to rounding.
The table shows Allstate's adjustments are narrow and mostly sensible: they strip out investment marks, pension marks and one-off sale gains, and they do not add back catastrophes or stock compensation. In 2026 the adjustments actually lowered earnings (adjusted $19.65 vs GAAP $21.73) because equity markets were strong. The memo rows are the part a reader needs: catastrophes take $9 to $15 a share in a normal year, and reserve releases have been adding $5 a share a half-year.
Exhibit 4 passes the basic cash test: over the last four quarters, operating cash flow was $12.5B against $11.9B of adjusted and $13.2B of GAAP net income. For an insurer that comparison flatters slightly, because growing premiums are collected before claims are paid, and it says nothing about the adequacy of reserves, which is where insurers' earnings quality problems hide. Favorable development indicates that prior accident-year loss estimates have generally proved conservative relative to subsequent claims emergence, although this does not establish that current reserves are similarly conservative.
Margin bridge. Allstate does not report a gross margin; the combined ratio is the margin, and the full-year 2025 split was a 63.8 loss ratio and a 21.4 expense ratio. TTM underwriting margin was about 19.6% (combined ratio ~80.4): roughly 21 points underlying, minus ~6 points of catastrophes, plus ~5 points of releases. On the underlying side, auto is the swing factor (87.6 recorded underlying in Q2, about 90 after the disclosed current-year benefit), while homeowners underlying rose 2.9 points to 61.5 on higher loss costs even as average premiums rose 5.8%. The cost pressure is visible in macro data: the September CPI shows motor vehicle maintenance and repair up 5.8% a year while motor vehicle insurance prices fell 5.0%. Expense discipline helps: the "Affordable, Simple, Connected" products and AI tools are designed to cut acquisition and claims costs.
Working capital. Not a meaningful signal for an insurer. The items to watch are premium installment receivables ($11.9B, growing with premiums) and the reserve-to-premium relationship discussed above.
Balance sheet stress points. Few on the liability side. Exhibit 5 shows book value per share rising from $70.35 to $123.38 since September 2024, almost entirely from retained earnings. Debt is $7.49B (18% of capital, 23% including $2.05B of preferred) and interest coverage is about 44x; statutory capital is covered in Section 3. The exposure is on the asset side: an $87.8B portfolio of which $60.8B is fixed income and $11.2B public equities (up from $8.4B at year-end).
Rates: a simplified duration sensitivity. Allstate's 10-K shows a +100bp parallel rise in risk-free rates would have cut the fair value of its interest-sensitive assets by about $3.0B pre-tax at year-end 2025 (duration 5.1 including derivatives), and a +100bp widening in credit spreads by about $2.1B. Duration has since lengthened, to about 5.7 years in Q1. The 10-year Treasury rose about 64bp from the end of June to late September and about 82bp to early October. Scaling the company's disclosure linearly gives roughly $1.9B to $2.8B pre-tax, or $6 to $9 a share after tax. This is not an estimate of the actual Q3 change in book value: it ignores curve shape (the move was not parallel), credit spreads, convexity and mortgage prepayment behaviour, hedges, portfolio turnover, security-level tax effects and the equity book. It shows the order of magnitude: rates alone could offset a large part of a quarter's earnings in reported book value, while leaving the equity base used for adjusted ROE (which excludes unrealized gains and losses) largely unchanged. The other side is higher reinvestment yields, already visible in market-based investment income (+14% in Q2).
Catastrophe reinsurance: what Allstate keeps before protection starts
The program renewed on 1 April 2026 protects the balance sheet against a single very large event far more than against a heavy year of mid-sized storms, and that is the distinction that matters for the normalization debate.
| Layer | 2026–27 terms | vs. 2025–26 |
|---|---|---|
| Per-occurrence retention (nationwide) | $1.0B per event, plus any reinstatement premium | Unchanged |
| Per-occurrence tower | $1.0B to $11.5B; traditional reinsurance to $4.75B, cat bonds in the upper layers; top layers drop down as lower layers erode (minimum retention $4.75B) | Top raised from $9.5B |
| Reinstatement | $4.75B–$6.75B traditional layer reinstatable with premium; cat-bond layers not reinstatable | Similar structure |
| Nationwide aggregate | $150M of limit for losses of $4.78B–$5.28B; $50M per-event deductible; excludes Florida | Down from $500M above $4.0B |
| New US aggregate (reported) | ~$1B of limit above ~$8.5B of losses; property and auto incl. Florida; $1B per-event cap | New; terms per trade press |
| Cat bonds | ~$3.8B outstanding incl. aggregate and Florida deals | Record $1.2B Sanders Re issue (Feb 2026) |
| Cost (ex reinstatements) | $308M in Q1 2026 vs $257M; $1.23B in 2025 (~2.1 pts of premium) | Rising |
| Recoverables | $7.88B at 30 Jun; at YE25 $5.83B Michigan MCCA, $0.90B catastrophe reinsurers (named reinsurers rated A to AA−) | Down from $8.50B (Dec) |
Sources: Artemis and Reinsurance News on the 1 April 2026 renewal (30 Apr–1 May 2026); Allstate 2025 10-K (reinsurance recoverables, probable maximum loss); Q2 2026 10-Q (recoverables at 30 June). The new US aggregate's terms are as reported by trade press and have not been confirmed in a company filing. Florida's separate program renews mid-year and is not detailed here.
Two implications follow. First, severe convective storms, which drove most 2026 losses, arrive as many events that each fall below the $1.0B occurrence retention, so they are largely retained; Artemis estimates losses in the aggregate risk period since April at about $3.15B through August (roughly $3.4B with September added), still short of the $4.78B aggregate attachment. Second, the tail is well covered: Allstate puts its modelled 1-in-100 probable maximum loss for hurricane, earthquake and wildfire at about $3.1B net of reinsurance (year-end 2025), but that figure excludes convective storms. A heavy storm year therefore flows mostly into earnings, which is why the catastrophe sensitivity in Section 6 matters more than the size of the tower. Litigation over claims handling and auto bodily injury trends remain industry risks; GEICO reported bodily injury severity up 10% to 12% in the first half.
Excess capital going back through buybacks, sized to a peak year
ROE vs. cost of equity. For an insurer, return on equity is the right analogue of ROIC: equity is the capital regulators and rating agencies require to write premium. Exhibit 6 shows how cyclical it is. Adjusted ROE was 16.9% in 2021, negative in 2022, about 1.5% in 2023 (our estimate), then 26.8%, 38.3% and 44.2% on a trailing basis. The five-year average is about 16.4%, against a cost of equity we put at 9.5% to 10.5% given a 5.26% 10-year yield. That spread is positive through the cycle but far smaller than today's figure suggests.
Buybacks & dividends. Allstate essentially stopped repurchasing in 2023 and 2024 to rebuild capital, then restarted: $1.2B in 2025 and $1.7B in the first half of 2026, including $1.05B in Q2. The board approved a $4.0B program in February 2026 after the prior $1.5B program finished, and $2.6B remained at 30 June. A straight-line pace to February 2028 would be about $500M a quarter, so the $1.4B used in roughly four and a half months is ahead of that pace; the CEO said on the Q2 call the company is "committed to completing" it. Exhibit 7 shows the share count falling 3.9% in a year, net of dilution. The heaviest quarter (Q2) came with the stock at roughly $205 to $237 between the March and June month-ends, below today's price, and the quarterly dividend was raised 8% to $1.08 in February. Cash returned over the last twelve months was about $3.6B, 31% of adjusted net income and a 5.8% trailing shareholder yield; dividends plus the remaining authorization spread evenly to February 2028 would be about 4.2% a year.
Capital strength: how much can come back through a bad year
The useful question is not whether Allstate has capital but how much it can return while keeping its ratings (Allstate Insurance Company's financial strength rating is A+ at A.M. Best, outlook stable), its regulatory capital, and enough surplus to grow premiums through a stressed catastrophe year. The disclosed pieces:
| Measure | Value | Context |
|---|---|---|
| Statutory surplus, all insurers | $22.95B (31 Dec 2025) | $18.64B a year earlier; P&C subsidiaries $22.85B |
| AIC total adjusted capital vs. authorized control level RBC | $20.75B vs $4.23B (~4.9x) | Regulatory action starts below 2x |
| Net premiums written / statutory surplus | ~2.6x (TTM NPW $60.3B) | Moderate for personal lines |
| AIC statutory net income, 2025 (inferred) | ~$8.0B; ~43% of average surplus | Statutory and GAAP returns both at a peak |
| AIC dividends to the parent | $3.95B paid in 2025 | Main source of holding company cash |
| AIC ordinary dividend capacity, 2026 | $7.98B less dividends paid in the prior 12 months | More requires 30 days' notice to the Illinois regulator |
| Holding company deployable assets | $7.52B (YE25); ~$9.5B (30 Jun, mgmt.) | vs $7.49B of debt; ~$37 a share |
| Remaining buyback authorization | $2.6B (30 Jun) | ~$500M a quarter straight-line to Feb 2028 |
| Modelled 1-in-100 PML, net of reinsurance | ~$3.1B (YE25) | Hurricane, earthquake, wildfire; excludes convective storms |
Sources: Allstate 2025 10-K (Regulation; Capital Resources and Liquidity); Q2 2026 call. Surplus and RBC are company estimates at 31 Dec 2025; "~4.9x" is our division. Statutory net income is inferred: the 2026 ordinary-dividend formula uses the greater of 2025 statutory net income or 10% of surplus, and $7.98B is far above 10% of surplus. Rating agency capital models (A.M. Best BCAR, S&P) are not public.
An illustrative stress, using our estimates: a 2023-like catastrophe year (11.6 points) instead of the 9.5-point base adds about $1.3B of pre-tax losses on 2027 premiums; adding a modelled 1-in-100 hurricane, earthquake or wildfire event ($3.1B net) takes the shock to about $4.4B pre-tax, roughly $3.5B after tax. That is about 15% of statutory surplus and well under the holding company's ~$9.5B of deployable assets, so on disclosed figures the remaining $2.6B buyback looks fundable even in a bad year. Two things the disclosures do not show: the capital rating agencies require to keep the A+ rating, which is the binding constraint in practice, and exactly how much surplus premium growth will absorb (roughly $1B a year at 4% to 5% growth and a 2.6x premium-to-surplus ratio, our estimate).
M&A and portfolio moves. The 2021 acquisition of National General (non-standard auto, independent agents) left $3.1B of goodwill and has been folded into the independent-agent strategy; the legacy National General homeowners book has been shrunk. Allstate exited life and annuities in 2021 and employer benefits and group health in 2025, simplifying toward property-liability. These have been value-sensible: capital was pulled from lower-return lines and redeployed into the core during its worst years. Reinvestment runway. Incremental capital funds premium growth (each dollar of new premium needs surplus), advertising and technology. Growth at the current ~20% underwriting margin is very profitable; growth bought with lower prices as the market softens will earn less.
No earnings guidance, six large beats, and the beats came from the same places
Allstate does not give EPS or combined-ratio guidance. Instead it publishes catastrophe losses monthly, which lets analysts update estimates in real time. So the "say/do" test has two parts: consensus vs. actual, and stated strategy vs. delivery.
| Quarter | Consensus | Actual | Beat | Of which releases (est.) | Beat excl. releases | Cat pts |
|---|---|---|---|---|---|---|
| Q1 2025 | $2.53 | $3.53 | +$1.00 | $0.70 (70%) | +12% | 15.7 |
| Q2 2025 | $3.87 | $5.94 | +$2.07 | $1.10 (53%) | +25% | 13.9 |
| Q3 2025 | $8.20 | $11.17 | +$2.97 | $1.16 (39%) | +22% | 3.8 |
| Q4 2025 | $9.60 | $14.31 | +$4.71 | $2.38 (50%) | +24% | 1.4 |
| Q1 2026 | $7.24 | $10.65 | +$3.41 | $3.07 (90%) | +5% | 8.4 |
| Q2 2026 | $5.76 | $8.99 | +$3.23 | $2.09 (65%) | +20% | 11.5 |
| Q3 2026 | $6.56 | 4 Nov | ~11 (disclosed) |
Newsletter estimates. Diluted share counts approximated as shares outstanding plus ~5M where not reported. Consensus at report date from Alpha Vantage; other providers show somewhat different figures for some quarters (for example Q3 2025 at $7.55), which do not change the sign of any beat.
The decomposition changes the read. Consensus usually assumes no reserve development, so favorable releases explain between 39% and 90% of each beat. Excluding them, Allstate still beat in every quarter, by 5% to 25%. That residual mixes three things the data cannot fully separate: catastrophe losses that differed from what analysts modelled (Q3 and Q4 2025 were exceptionally light at 3.8 and 1.4 points), higher investment income (net investment income rose from $949M in Q3 2025 to $1.01B in Q2 2026), and genuine underlying improvement. The smallest residual came in Q1 2026 (+5%), the quarter with the largest release.
| Item | Said | Delivered |
|---|---|---|
| Q1 2026 EPS | Consensus $7.24 | $10.65 beat, $838M auto reserve release (8.8 pts) |
| Q2 2026 EPS | Consensus $5.76 | $8.99 beat, cats −13.5% YoY, 4.6 pts of releases |
| Q3 2026 EPS | Consensus $6.56 (cats known) | pending, 4 Nov |
| Transformative Growth: grow auto policies | Return auto PIF to growth | +2.8% YoY (Q2), new business +8.8% delivered |
| $4.0B buyback (approved Feb 2026) | Complete by Feb 2028 | $1.4B used by 30 Jun vs ~$0.75B straight-line ahead of pace |
| Divest non-core (EVB, group health) | Announced 2024 | Closed 2025, ~$1.6B gains delivered |
Consensus at report date from Alpha Vantage; other data sources show slightly different figures for some quarters (for example Q3 2025 at $7.55), which do not change the direction of any beat. Buyback used = $4.0B minus $2.6B remaining (management, Q2 call); straight-line pace = $4.0B over 24 months.
Say vs. do. On strategy, management has done what it said: policy growth returned, buybacks are running ahead of a straight-line pace and the portfolio is simpler. On earnings, the decomposition above says the beats came mainly from the components analysts do not model, reserve releases and catastrophe variance, with a smaller but consistent residual. Narrative vs. numbers: the "affordability" message (lower prices for 7.8 million customers in 2025) is consistent with flat auto rates and falling premium per policy, and the margin that funds it is real. What the narrative does not stress is that auto written premium is now growing more slowly than auto policies.
Steady insider selling into the rally, pay tied to cat-adjusted ROE
Insiders. Insiders own roughly 0.5% to 1% of the shares. The Form 4 record over the past twelve months:
| Item | Detail |
|---|---|
| Open-market purchases | None |
| Open-market sales | ~58 transactions, ~379,000 shares, ~$84M (17 Oct 2025 to date) |
| Rule 10b5-1 plan sales | CEO Tom Wilson: about 185,000 shares (~$38M) between late October 2025 and mid-March 2026; his January 2026 Form 4 states the sales were made under a plan adopted 27 June 2025. No sales reported since March. |
| Sales after option exercises | COO Mario Rizzo exercised 56,225 options (strike $92.46, due 2029) on 11 August and sold the same number at about $264 to $266; the filing does not mark it as a 10b5-1 trade. Other officer sales, including about 33,000 shares by John Dugenske on 7 August at $268 to $272 and sales by Jesse Merten and Suren Gupta, partly followed exercises. |
| Shares retained | Wilson: 111,215 held directly after his 2 January sales, plus about 786,000 in trusts, GRATs and the 401(k) plan (~897,000 in total). Rizzo: 82,227 held directly after the August sale. |
Sources: Form 4 filings (Wilson, filed 6 Jan 2026; Rizzo, filed 12 Aug and 3 Oct 2026); Alpha Vantage insider transactions for totals. 10b5-1 status is shown only where stated in the filings named; totals are approximate.
Institutions & positioning. 13F filers hold about 71%, led by BlackRock (8.5%), Vanguard entities (~11.9% combined) and State Street (4.8%), with little change quarter to quarter. Short interest is low at about 2.5% to 2.7% of float and ~4.5 days to cover (August to September), down from earlier in the year. Sell-side views have cooled: UBS and HSBC moved to Hold in July, Argus to Hold and KBW to Underperform in August (KBW target cut to $232 in October), while Raymond James sits at $300.
Compensation. The 2026 to 2028 performance stock awards pay 60% on average performance net income ROE, with catastrophe losses collared to a minimum and maximum and equity measured excluding unrealized gains, and 40% on relative total shareholder return (2026 proxy). That is better aligned than revenue or EBITDA targets: it rewards per-share returns over three years and stops management from being paid for lucky weather. Two caveats: reserve releases still count toward the ROE metric, and adjusted measures also feed the annual incentive.
Cheap on peak earnings; the price sits between through-cycle and current returns
At $247.88, Allstate trades at 5.5x trailing adjusted EPS, 7.0x 2026 consensus and 8.8x 2027 consensus, and at 2.01x book ($123.38 at 30 June). For an insurer whose earnings swing from losses to records, P/E history is close to useless: year-end P/E was 8.7x in 2021, not meaningful in 2022 (loss) and 2023 (147x on $0.95), 10.5x in 2024 and 6.0x in 2025. Price to book is the steadier anchor, provided the return and the book value are measured on the same basis.
Three bases, kept consistent
| Basis | Return (TTM) | Book or capital | Multiple |
|---|---|---|---|
| GAAP | 49.1% ROE: net income to common ÷ average common equity | $123.38 BVPS | 2.01x P/B |
| Adjusted (company-defined) | 44.2%: adjusted net income ÷ common equity excl. unrealized gains and losses | $124.13 BVPS excl. AOCI | 2.00x P/B |
| Statutory | ~43%: AIC 2025 statutory net income ÷ average surplus (inferred) | $22.95B surplus (YE25) | 2.74x market cap ÷ surplus |
GAAP and adjusted ROE as reported by Allstate for the twelve months to 30 June 2026. Book excl. AOCI adds back $193M of accumulated other comprehensive loss using the company’s diluted book-value share denominator (approx. 256.9M); at 30 June the two book values differed by under 1%, but the gap will widen if Q3 bond marks are large. Statutory surplus excludes deferred acquisition costs, goodwill and non-admitted assets and sits in the operating insurers, not the holding company, so market cap ÷ surplus is shown for scale only. In the justified-multiple work below, return assumptions are adjusted ROE applied to book value excluding AOCI ($124.13), so numerator and denominator match.
Versus its own history. Exhibit 9 shows year-end P/B between 1.44x (2021, before the loss years) and 2.66x (2024, when book was still recovering and earnings were inflecting). Today's 2.01x is 14% below the 2.34x median, but that median flatters the comparison: in 2022 and 2023 book value was depressed by underwriting losses and unrealized bond losses, so the market paid a high multiple for a temporarily small denominator.
What the price implies
For an insurer the multiple of book a stock deserves depends on the ROE it can sustain: P/B = (ROE − g) ÷ (CoE − g). Two of the three inputs are assumptions. Cost of equity (CoE) is set at 9.5% to 11.0% (10-year Treasury 5.26% plus a 4 to 6 point premium); CAPM with the measured 0.13 beta would give an implausibly low ~6%. Long-run growth (g) should be tied to the business: book value has to grow roughly with premiums to keep premium-to-surplus stable, and g = ROE × the share of earnings retained. At a 15% ROE, 4% growth means retaining about 27% of earnings and distributing 73% through dividends and buybacks. Allstate distributed 31% of adjusted earnings over the last year because earnings are at a peak; over a full cycle, payout has to rise or book value outgrows the premium base. A 2% to 5% range brackets nominal premium growth over a cycle.
| Implied ROE at 2.00x | CoE 9.5% | 10.5% | 11.0% |
|---|---|---|---|
| g = 2% | 17.0% | 19.0% | 20.0% |
| g = 3% | 16.0% | 18.0% | 19.0% |
| g = 4% | 15.0% | 17.0% | 18.0% |
| g = 5% | 14.0% | 16.0% | 17.0% |
Sustainable adjusted ROE implied by today's price on book excl. AOCI: ROE = g + P/B × (CoE − g).
| Justified P/B, CoE 10.5% | g 2% | g 3% | g 4% |
|---|---|---|---|
| ROE 15% | 1.53x | 1.60x | 1.69x |
| ROE 18% | 1.88x | 2.00x | 2.15x |
| At g = 5%: 15% · 18% | 1.82x · 2.36x | ||
Growth matters less than cost of equity: moving g from 2% to 5% shifts the multiple by about 0.3x to 0.5x.
| Justified P/B (g 4%) · value per share | CoE 9.5% | CoE 10.5% | CoE 11.0% | |
|---|---|---|---|---|
| Sustained adjusted ROE 12% | 1.45x · $181 | 1.23x · $153 | 1.14x · $142 | |
| 15% | 2.00x · $248 | 1.69x · $210 | 1.57x · $195 | |
| 18% | 2.55x · $316 | 2.15x · $267 | 2.00x · $248 | |
| 20% | 2.91x · $361 | 2.46x · $306 | 2.29x · $284 |
Newsletter estimates. Value = justified P/B × $124.13 book value per share excl. AOCI (30 Jun 2026).
The price implies a sustainable adjusted ROE of roughly 14% to 20%, centred near 17% (CoE 10.5%, g 4%). That is a range rather than a point, and the cost-of-equity choice moves it more than growth does.
Normalized earnings: three cases and a through-cycle anchor
| 2027 assumption | Bear | Through-cycle | Base | Bull |
|---|---|---|---|---|
| P-L premiums earned | $60.0B | $61.5B | $61.5B | $63.0B |
| Auto underlying CR | 94 | not set | 91 | 89 |
| Homeowners underlying CR | 65 | not set | 63 | 61.5 |
| Catastrophe load | 11.5 pts | not set | 9.5 pts | 8.0 pts |
| Prior-year development | 0.5 pts adverse | none | none | 1.5 pts favorable |
| Recorded P-L combined ratio | 97.3 | 94.8 (10-yr avg) | 92.1 | 87.3 |
| Net investment income | $3.9B | $4.1B | $4.1B | $4.3B |
| Diluted shares | 248M | 245M | 245M | 240M |
| Adjusted EPS | ~$17 | ~$23 | ~$28 | ~$39 |
| Adjusted ROE on average 2027 book | ~12% | ~15–16% | ~19% | ~26% |
| P/E at $247.88 | 14.8x | 11.0x | 8.9x | 6.3x |
Newsletter estimates. Other personal and commercial lines underlying at 82 (bear), 80 (base), 79 (bull). Line weights from 6M 2026 premiums earned (auto 64.6%, homeowners 28.1%, other 7.3%); 0.3 pts of intangibles amortization added. Pre-tax income = underwriting income + net investment income less ~$160M of other items (Protection Services, interest, corporate; calibrated so the method reproduces TTM adjusted net income of $11.9B); 21% tax; ~$110M preferred dividends. Through-cycle case applies Allstate's ten-year average property-liability combined ratio of 94.8 (Q2 2026 investor presentation) to 2027 premiums with today's investment income. Book path uses FY2026 consensus earnings, then dividends and buybacks near the current pace. Consensus FY2027: $28.11 (22 analysts, $23.55–$34.35).
The base case lands on consensus, which is a cross-check rather than a target: it needs auto underlying margins about a point worse than today and a catastrophe load between 2025's 8.6 points and the nine-month ten-year average. The through-cycle anchor is the more conservative lens: if Allstate simply matches the last decade's average combined ratio with today's investment income, it earns about $23 a share and about 15% to 16% on equity, at the low end of the 14% to 20% the price implies. The base case (~19%) sits at the high end. On these numbers the share price embeds returns somewhere between a full cycle and a mild softening.
Catastrophe sensitivity
| Adjusted EPS at a catastrophe load of | 7 pts | 9 pts | 10.3 pts | 12 pts |
|---|---|---|---|---|
| TTM, excl. reserve releases (actual 6.3 pts: $36.42) | $35.2 | $31.6 | $29.3 | $26.3 |
| 2027 base case (other assumptions unchanged) | $32.9 | $28.9 | $26.3 | $22.9 |
Newsletter estimates. Each point of catastrophe load is worth about $1.8 (TTM) to $2.0 (2027) a share after tax. Reference points: Allstate's full-year catastrophe ratio was 11.6 (2023), 9.2 (2024) and 8.6 (2025); its ten-year average for the first nine months of the year, the heaviest part of the year, was 10.3 as of 2025, so a full-year ten-year average would be lower.
No single number is "normal". Rebuilding-cost inflation, higher property values, a peril mix shifting toward convective storm and wildfire, and Allstate's own geographic shifts all argue that history may understate the forward load, which is why the table brackets it rather than picking one.
Other measures
Dividend plus buyback yield: 5.8% trailing ($3.6B returned on a $62.8B market cap), about 4.2% forward if the remaining $2.6B is spread evenly to February 2028. Normalized P/E: 8.9x the base case and 11.0x the through-cycle anchor. Peer P/B: Progressive trades at 3.70x book on a 32.5% ROE and auto policy growth of about 7%; Allstate's 2.0x prices a lower sustainable return. Sell-side: consensus is "Moderate Buy" across about 24 analysts, with mean targets of roughly $265 to $274 depending on the source and a range of $226 to $300.
Late in the auto cycle, early in a rate cycle that cuts both ways
Cycle. Personal auto is moving from a hard market to a soft one. The evidence is broad: the BLS motor vehicle insurance index fell 5.0% year on year in September, its fifth straight year-on-year decline after the first in May; Progressive's monthly combined ratio drifted from 86.8 in July to 90.0 in September; GEICO's Q2 combined ratio rose 7.7 points; and the five largest Florida writers, Allstate included, filed average 8% cuts for 2026. Allstate's margin is still wide (auto recorded combined ratio 83.3 in Q2), so it can compete on price for a while, but the direction of margin is down. Homeowners is earlier in its cycle: rates are still rising mid-single digits to keep up with replacement costs and storms.
Macro. The Fed raised its target range by 25bp to 3.75%–4.00% on 16 September (12–0), its first move since cutting to 3.50%–3.75% in December 2025, citing elevated inflation; the median projection implies one more hike by year-end. September CPI, released 14 October, was 3.7% headline and 2.6% core, above expectations, and one market report put odds of an October hike near 47% afterwards. For Allstate the effects split: higher yields raise investment income on new money (positive), mark down existing bonds and book value (negative near term) and raise the discount rate on its equity (negative for the multiple). Energy-led inflation can also reduce miles driven and claim frequency, a modest potential offset, while repair costs (+5.8%) keep severity rising.
Near-term catalysts. (1) FOMC decision, 28 October. (2) Q3 2026 results, 4 November (call 5 November): cats are known, so the variables are the underlying auto combined ratio, whether reserve releases continue, the size of the AOCI hit to book value, auto rate actions and retention, and buyback pace against $2.6B remaining. (3) October CPI, 10 November, for the motor vehicle insurance and repair indexes. (4) October catastrophe release, typically mid-November. (5) Progressive's October results, 18 November, the best real-time read on industry pricing. (6) End of hurricane season, 30 November; Q3 was a light hurricane quarter for Allstate (September cats $220M).
Second-order tells. Progressive's monthly combined ratio and policy growth; GEICO's Q3 results inside Berkshire Hathaway's filing in early November; the BLS repair, parts and used-car indexes (used cars −1.5% a year in September, a mild help to physical damage severity); state rate filings; and Allstate's monthly policies-in-force data.
What has to go right, and what breaks it
Bull: what has to go right
- A shallow soft market. Auto underlying combined ratio holds near 89, catastrophes run near 8 points and releases continue modestly. That is our bull case: about $39 of 2027 EPS and a ~26% ROE, well above the 14% to 20% the price implies.
- Capital return through the cycle. ~$9.5B of holding company assets and $7.98B of 2026 ordinary dividend capacity at the main insurer cover the remaining $2.6B buyback even after an illustrative stress year, while reinvestment at 5%+ yields keeps lifting investment income.
- A demonstrated underwriting edge. A ten-year auto combined ratio of 95.2 against 100.3 for the industry, and 92.0 against 102.2 in homeowners, says Allstate can earn a margin through a soft market that peers cannot.
Bear: what breaks the thesis
- Price war meets severity. Auto insurance prices are falling 5% a year nationally while repair costs rise 5.8% and bodily injury severity rises faster (GEICO: +10% to 12% in the first half). Our bear case (auto underlying 94, cats 11.5 points, slight adverse development) gives about $17 of EPS and a ~12% ROE; at 1.2x to 1.5x book that is roughly $170 to $215.
- A peak flattered by non-repeatable items. About $8.70 of trailing EPS came from reserve releases and another $5 to $7 from catastrophes below a 9 to 10.3 point load; releases explained 39% to 90% of each recent beat. A reversal into reserve strengthening, as in 2022, would hit earnings and the capital behind the buyback.
- Retained storm risk and rates. Convective storms sit mostly below the $1.0B occurrence retention, so a heavy storm year is retained. With the Fed hiking and the 10-year above 5%, unrealized losses on a $61B bond book weigh on reported book value, and a higher cost of equity compresses the multiple.
| Cycle dashboard | Latest | Constructive if | Concerning if |
|---|---|---|---|
| Auto underlying combined ratio | 87.6 (Q2; ~90 ex-benefit) | ≤88 | >92 |
| Auto written premium growth | +0.4% (Q2) | Catching up with policy growth | Negative |
| Auto policies in force growth | +2.8% (Q2) | ≥2%, stable premium per policy | Falling |
| Homeowners underlying combined ratio | 61.5 (Q2) | ≤62 | >65 |
| Prior-year reserve development | +4.6 pts favorable (Q2) | Favorable or neutral | Adverse |
| Catastrophe load | 11.5 pts (Q2); ~11 (Q3, disclosed) | ≤9.5 pts over a year | >12 pts over a year |
| Book value per share | $123.38 (Jun) | Grows despite rate marks | Falls QoQ |
| Quarterly buybacks | $1.05B (Q2) | ≥$0.5B (straight-line pace) | <$0.5B |
Thresholds are newsletter judgment, set against recent run-rates; they are monitoring markers, not a rating.
Definitions. Fiscal year = calendar year; Q2 2026 = quarter ended 30 June 2026. TTM = Q3 2025 to Q2 2026. "Adjusted" net income and EPS are company-defined (excluding net investment and derivative gains and losses, pension remeasurement, purchased-intangible amortization, disposition gains and related tax); they include catastrophe losses and prior-year reserve development and do not add back stock compensation. Combined ratio = claims, claims expense and operating costs ÷ premiums earned; underlying combined ratio excludes catastrophes, prior-year non-catastrophe reserve re-estimates and intangible amortization. GAAP ROE uses average common equity; adjusted ROE uses common equity excluding unrealized gains and losses; justified P/B pairs adjusted ROE with book value excluding AOCI. Reserve-release and catastrophe per-share effects apply a 21% tax rate to disclosed points × premiums earned. Q3 2026 catastrophe ratio uses disclosed $1.65B over estimated ~$15.0B premiums earned. Rate sensitivity scales the company's disclosed +100bp sensitivity linearly (simplified; see Section 2). Justified P/B = (ROE − g) ÷ (CoE − g); implied ROE = g + P/B × (CoE − g). Scenario EPS: line-level underlying ratios plus catastrophe and reserve assumptions, investment income, ~$160M other pre-tax items, 21% tax, ~$110M preferred dividends. Beta from 60 monthly adjusted returns vs SPY. Year-end P/B uses December month-end closes. 2023 adjusted ROE is estimated from adjusted EPS of $0.95. RBC multiple, statutory return and the stress illustration are newsletter calculations from company disclosures.
Company sources. Q2 2026 earnings release and Form 8-K (5 Aug 2026), Q2 2026 10-Q, Q2 2026 investor presentation (ten-year combined ratios; accident-year mix of auto injury releases, via Investing.com, Aug 2026), Q1 2026 release (29 Apr 2026), Q4 and FY2025 release (4 Feb 2026), 2025 Form 10-K and annual report (statutory surplus, RBC, dividend capacity, holding company assets, interest-rate and spread sensitivity, reinsurance recoverables, expense ratios, probable maximum loss), Q3 2025 release (5 Nov 2025), Q4 2022 and Q4 2024 releases (book value history), 2026 proxy statement (DEF 14A), monthly catastrophe releases for July (20 Aug), August (17 Sep) and September 2026 (15 Oct), Q3 2026 earnings date announcement (5 Oct 2026), dividend announcement (8 Jul 2026), Form 4 filings (Wilson, 6 Jan 2026; Rizzo, 12 Aug and 3 Oct 2026), Q2 2026 call summaries (GuruFocus, MarketBeat).
Market, peer & macro sources. Alpha Vantage (income statement, balance sheet, cash flow, earnings history and estimates, monthly adjusted prices for ALL and SPY, PGR quote, weekly 10-yr Treasury yield, insider transactions; retrieved 17 Oct 2026); Artemis and Reinsurance News on the April 2026 reinsurance renewal (30 Apr–1 May 2026) and aggregate-period losses (Sep 2026); Federal Reserve FOMC statement (16 Sep 2026); BLS CPI for September 2026 (14 Oct 2026, via InvestingLive and Stock Titan); Progressive September 2026 results (via Finviz, 14 Oct 2026) and Q2 2026 results (Zacks, 14 Aug 2026); GEICO Q2 2026 from Berkshire Hathaway's 10-Q (via actuary.info and Coverager, Aug 2026); State Farm 2025 results release (26 Feb 2026); Florida Office of Insurance Regulation (5 Mar 2026); S&P Global Market Intelligence 2026 P&C outlook (Jan 2026); Tickeron and TradingKey on the 22 Sep 2026 decline; Barchart, Benzinga and StreetInsider for ratings and targets; Equibles and Benzinga for short interest; VCP Scanner and Simply Wall St for institutional ownership (13F, Q1 2026).
Follow-up from prior reports
Research Ledger
Historical intraday highs from the original profile baseline through October 16, 2026, shown separately from the October 16 closing-price change. These are price observations, not portfolio or total returns.
| Security | Original view / date | Performance since profile | Current state | What changed | Next review |
|---|---|---|---|---|---|
| FRO · Frontline PLC | Bullish / Aug. 16, 2026 | +44.99% peakBaseline $41.21 · High $59.75 (Oct 13)Oct 16 close $52.49 · +27.37% vs. baseline | Bullish thesis / Rebound | Peak-to-baseline and Friday-close changes measured against the original profile baseline; excludes dividends, fees and slippage. | Tanker rates / routes |
| GILD · Gilead Sciences, Inc. | Bullish / Aug. 23, 2026 | +9.85% peakBaseline $146.12 · High $160.51 (Oct 15)Oct 16 close $156.19 · +6.89% vs. baseline | Bullish thesis / Under pressure | Peak-to-baseline and Friday-close changes measured against the original profile baseline; excludes dividends, fees and slippage. | Q3 / pipeline updates |
| TK · Teekay Corporation | Bullish / Sep. 6, 2026 | +16.65% peakBaseline $13.63 · High $15.90 (Oct 12)Oct 16 close $14.06 · +3.15% vs. baseline | Bullish thesis / Rebound | Peak-to-baseline and Friday-close changes measured against the original profile baseline; excludes dividends, fees and slippage. | Tanker-rate review |
| HOOD · Robinhood Markets, Inc. | Neutral / Sep. 20, 2026 | +5.78% peakBaseline $119.82 · High $126.74 (Sep 23)Oct 16 close $98.87 · -17.48% vs. baseline | Neutral / Volatile | Peak-to-baseline and Friday-close changes measured against the original profile baseline; excludes dividends, fees and slippage. | Q3 / operating data |
| JCI · Johnson Controls International | Neutral / Sep. 27, 2026 | +6.80% peakBaseline $150.20 · High $160.41 (Oct 6)Oct 16 close $145.47 · -3.15% vs. baseline | Neutral / Valuation-sensitive | Peak-to-baseline and Friday-close changes measured against the original profile baseline; excludes dividends, fees and slippage. | Q4 / FY27 guidance |
| ALL · The Allstate Corporation | Research framework / Oct. 18, 2026 | Baseline issueInitial profile · October 16 closing price | Valuation-sensitive / underwriting cycle | New October 18 profile; no post-publication performance period yet. | Nov. 4 · Q3 earnings |
Price observations through Friday, October 16, 2026. Baselines are unchanged from original profile publication; highs are intraday, current changes use closing prices.
The events most likely to alter the thesis
Risk & Event Calendar
Week of October 19–23, 2026. Event timing is subject to change; consult issuer and agency calendars for updates.
Focus on AI capex and monetization, automotive pricing, consumer margins and forward guidance. Dates vary by issuer.
Testing interest-rate sensitivity and whether housing activity can stabilize amid high financing costs.
Labor and growth signals that matter when bond yields are declining amid equity volatility.
Watch services input prices, manufacturing orders and inflation expectations after the September CPI surprise.
Upcoming meeting outside this reporting week; the Fed blackout period constrains official commentary.
Underlying auto combined ratio, reserves, bond marks, policies and repurchases will test the feature’s scenarios.
Earnings Calendar · October 19–23, 2026
Most anticipated earnings releases, organized by day and before/after market close.
Source and image credit: Earnings Whispers · Most Anticipated Earnings Releases, week beginning October 19, 2026. Earnings dates and times may change; confirm with company investor-relations announcements.
Insider activity and positioning
Insider Buys / Sells
Insider transactions are discussed only where a dated public filing is identified; an absence of featured transactions should not be interpreted as proof that no trading occurred.
Allstate-specific historical context: Vince’s supplied fundamental report references previous open-market and trading-plan sales, including CEO Tom Wilson’s earlier 10b5-1-plan transactions and officer option-exercise-related sales. Those are historical observations, not evidence of fresh October 12–16 discretionary sales.
Vince Vora’s analysis
The $745 Billion Blind Spot: Why Wall Street’s AI Obsession Is About to Backfire
Stop looking at the inflation numbers. Forget the Federal Reserve meeting minutes, and put down the stale debate over government debt auctions. While the financial media keeps you distracted with the exact same tired macro talking points week after week, a massive, multi-hundred-billion-dollar collision is happening right beneath the surface, and it’s about to blindside almost every trader in the market.
Here is the dirty secret nobody on TV is talking about: the AI trade has officially outgrown free cash flow.
For the last few years, tech giants built their artificial intelligence empires using mountains of cash they already had sitting in the bank. But that era is officially over. To fund the physical reality of this revolution, the sprawling data centers, the multi-billion-dollar chip fabs, and the massive electrical grid tie-ins, these companies are raiding the corporate bond market at an unprecedented pace.
Global AI-linked debt sales have surged to roughly $450 billion, more than doubling prior trends, while total planned tech capital expenditure commitments are scaling rapidly past $745 billion.
And this is where the trap snaps shut for everyday traders.
When hyper-growth tech companies flood the credit markets alongside heavy sovereign borrowers, they aren't price-sensitive. They need the capital now to win the race for dominance, meaning they are willing to pay whatever coupon it takes to clear the market. That creates an artificial floor on borrowing costs that trickles through the entire financial system, quietly competing directly with government paper for institutional liquidity.
So, what does this mean for your P&L on Monday morning? How do you actually trade this structural shift instead of just reading about it?
Here are three concrete ways to position your portfolio right now:
1. Watch the Credit Spread Divergence, Not Just Equity Tickers
When heavy corporate bond supply hits the market, credit spreads should theoretically blow out as institutional buyers demand higher risk premiums. Yet, investment-grade spreads have stayed stubbornly tight. Why? Because equity momentum is masking underlying fixed-income fatigue. The moment credit spreads start to widen while tech equities stall, you are looking at institutional liquidity exhaustion. Use the ratio between high-yield junk bonds and stable investment-grade corporate bond ETFs (like tracking HYG versus LQD) as your ultimate canary in the coal mine: when this ratio rolls over, it means smart money is fleeing risk because debt plumbing is getting congested.
2. Audit Your Portfolio’s "Double Concentration" Risk
Most traders think they are diversified because they hold a mix of high-flying tech stocks and stable corporate bond funds. But here’s the catch: as tech giants become dominant issuers in the corporate debt market, the exact same balance sheet risk is creeping into both sides of your portfolio. If a major tech issuer hits a roadblock or debt gets too expensive to service, you get hit simultaneously in your growth equities and your fixed-income allocations. Run a correlation check on your holdings, you might be far more concentrated in the AI trade than your dashboard suggests.
3. Shift Focus from Growth Momentum to Balance Sheet Fortitude
In a regime where the baseline cost of capital is being structurally pushed higher by massive corporate borrowing, cash-burning growth companies face a very different reality than cash-generative powerhouses. When trading individual equities or setting up options structures over the coming quarters, pivot away from companies relying on cheap floating-rate debt to fund expansion. Look for companies with rock-solid balance sheets, low debt-to-equity ratios, and the ability to self-fund operations without tapping this crowded debt plumbing.
The bottom line is this: the easy money of the initial AI wave was made by just buying the headline winners. The next phase won't be won by stock pickers, it will be mastered by the traders who understand how liquidity is actually moving behind the scenes. Keep your eyes on the plumbing, protect your capital, and don't let the mainstream narrative blind you to what's really happening.
Sources & Methodology
Market commentary is as of Friday October 16, 2026. The proprietary VMF and technical charts come exclusively from Vince’s October 18 document. Forward-looking research scenarios are estimates, not company guidance. Editorial conclusions are distinguished from source observations.
- AP · U.S. index closes and October 12–16 weekly returns
- Reuters · October 16 equities, AI selloff and oil backdrop
- MarketWatch · Weekly breadth and leadership rotation
- Financial Times · Technology and rates weekly context
- Reuters · Regional bank earnings and loan demand
- Reuters · CoreWeave credit and AI infrastructure concerns
- Kiplinger · October 19–23 economic calendar
- Stock Titan · October 19–23 earnings calendar
- Allstate investor relations · Q2 2026 results, 10-Q and Q3 event disclosures
- SEC EDGAR · Company filings and Form 4 verification
- ChartExchange · Daily ETF unadjusted closing-price history, Oct. 9 and 16 (each corresponding ETF page)
Index returns are Friday-to-Friday; sector proxy returns are October 16 close divided by October 9 close minus one, using unadjusted ETF closes at ChartExchange. VMF remains an independent ranking. Research Ledger retains October 9 historical performance values and does not imply a complete October 16 price refresh.
Stage 2 uptrend; ascending channel. Target #1 ~$434; extensions $455.61 and $510.75. Weekly close below 40-week average / channel near $340 invalidates.
Technical targets are scenarios rather than guaranteed outcomes; watch the stated invalidation levels.